LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
32 funds hold it · Insiders net selling
Net selling: insiders sold $18.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net buying of $2K to $30K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 27, 2026
Financial period
Q3 2026
Earnings per share
$6.74 expected
Revenue
$19.32B expected
FY 2026 guidance
$77.00B to $79.50B
No comparable estimate
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 27, 2026 | $7.22est. $6.74 | +7.12%beat | $19.85Best. $19.32B+2.71% | +3.6%from $19.16B |
| Jun 30, 2026Reported Jul 24, 2026 | $7.59est. $7.57 | +0.26%in line | $20.23BCompany release | +8.7%from $18.61B |
| Mar 31, 2026Reported Apr 24, 2026 | $7.15est. $7.13 | +0.28%in line | $19.11BSEC filing | +4.3%from $18.32B |
| Dec 31, 2025Reported Jan 27, 2026 | $8.01est. $7.48 | +7.09%beat | $19.51BAlpha Vantage | +6.7%from $18.29B |
| Sep 30, 2025Reported Oct 24, 2025 | $6.96est. $5.73 | +21.47%beat | $19.16BSEC filing | +9.6%from $17.49B |
| Jun 30, 2025Reported Jul 25, 2025 | $6.84est. $6.32 | +8.23%beat | $18.61BSEC filing | +6.4%from $17.49B |
| Mar 31, 2025Reported Apr 25, 2025 | $6.45est. $5.75 | +12.17%beat | $18.32BSEC filing | +5.7%from $17.34B |
| Dec 31, 2024Reported Jan 24, 2025 | $6.22est. $6.14 | +1.30%beat | $18.29BAlpha Vantage | +5.7%from $17.30B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $19.51B | $19.11B | $20.23B | $19.85B |
| Cost of what it sold | $11.34B | $16.25B | $17.16B | $16.89B |
| Gross profit | $8.18B | $2.86B | $3.07B | $2.96B |
| What it spent | ||||
| Sales and admin | $8.36B | — | — | $7.86B |
| Other operating costs | -$3.36B | $16.25B | $17.16B | $9.04B |
| Total operating expenses | $5.00B | $16.25B | $17.16B | $16.91B |
| What was left | ||||
| Operating profit | $3.18B | $2.86B | $3.07B | $2.96B |
| Interest on debt | $572.0M | $584.0M | $599.0M | $607.0M |
| Profit before tax | $2.67B | $2.29B | $2.49B | $2.37B |
| Tax | $509.0M | $430.0M | $564.0M | $521.0M |
| Net profit | $1.88B | $1.62B | $1.70B | $1.58B |
| EBITDA | $4.16B | $3.80B | $4.01B | $3.93B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
CVRx enables first Barostim implant access at Vassar Brother Medical Center
Leans bullishNov 12INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
BearishNov 12Hospitals write off $132B as AI fails to move the needle with finances
Leans bearishNov 12What Really Drove HCA Stock Higher?
Leans bullishNov 11HCA Healthcare svp Erica Rossitto sells $1.77M in stock By Investing.com
NeutralNov 11HCA HEALTHCARE NAMED A BEST EMPLOYER FOR VETERANS BY MILITARY TIMES FOR SEVENTH CONSECUTIVE YEAR
BullishNov 11Pictet Asset Management Holding SA Sells 45,456 Shares of HCA Healthcare, Inc. $HCA
Leans bullishNov 11HCA Healthcare, Inc. (NYSE:HCA) Stock Has Consensus Target Price of $480.13 According to Analysts
Leans bullishNov 1133 macro signals shaping HCA right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
